The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study.
Hung-Yi ChenJing-Yang HuangWun-Zhih SiaoGwo-Ping JongPublished in: Cardiovascular diabetology (2020)
Patients with type 2 DM prescribed with SGLT2 inhibitors were associated with a lower risk of all-cause mortality and NOA compared with those not taking SGLT2 inhibitors in real-world practice.